SEC Info - Nymox Pharmaceutical Corp - ‘20-F’ for 12/31/19

SEC Info℠

Home

Help

Please Sign In

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/19 – ‘R16’

On: Monday, 3/30/20, at 3:36pm ET · For: 12/31/19 · Accession #: 1640334-20-668 · File #: 1-12033

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/30/20  Nymox Pharmaceutical Corp         20-F       12/31/19  107:5.1M                                   Pubco Reporting … Inc/FA

Annual Report by a Foreign Non-Canadian Issuer — Form 20-F — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report by a Foreign Non-Canadian Issuer      HTML    722K 
 4: EX-13.A     Annual or Quarterly Report to Security Holders      HTML     25K 
 5: EX-13.B     Annual or Quarterly Report to Security Holders      HTML     25K 
 2: EX-12.A     Statement re: Computation of Ratios                 HTML     30K 
 3: EX-12.B     Statement re: Computation of Ratios                 HTML     30K 
59: R1          Document and Entity Information                     HTML     54K 
92: R2          Consolidated Statements of Comprehensive Income     HTML     78K 
82: R3          Consolidated Statements of Financial Position       HTML     87K 
22: R4          Consolidated Statements of Financial Position       HTML     28K 
                (Parenthetical)                                                  
58: R5          Consolidated Statements of Cash Flow                HTML     93K 
91: R6          Consolidated Statements of Changes in Equity        HTML     73K 
81: R7          Business Activities and Basis of Presentation       HTML     37K 
21: R8          Going Concern Considerations                        HTML     30K 
60: R9          Significant Estimates                               HTML     28K 
97: R10         Significant Accounting Policies                     HTML     76K 
62: R11         New Accounting Standards and Interpretations        HTML     30K 
27: R12         Property and Equipment                              HTML     89K 
39: R13         Intangible Assets                                   HTML     29K 
96: R14         Accounts Payable and Accrued Liabilities            HTML     38K 
61: R15         Convertible Notes                                   HTML     40K 
26: R16         Operating Leases and Commitments                    HTML     42K 
38: R17         Share Capital                                       HTML     41K 
95: R18         Stock Options                                       HTML     51K 
63: R19         Share Based Compensation                            HTML     37K 
19: R20         Warrants                                            HTML     59K 
57: R21         Income Taxes                                        HTML     60K 
94: R22         Earnings Per Share                                  HTML     35K 
84: R23         Financial Instruments Fair Value Disclosures        HTML     29K 
18: R24         Finance Income and Finance Costs                    HTML     52K 
56: R25         Segment Disclosures                                 HTML     43K 
93: R26         Concentrations                                      HTML     32K 
83: R27         Related Party Transactions                          HTML     39K 
20: R28         Research and Development Expenses                   HTML     40K 
55: R29         Personnel Expenses                                  HTML     37K 
35: R30         Capital Disclosures and Financial Risk              HTML     29K 
24: R31         Foreign Exchange Risk                               HTML     28K 
64: R32         Credit Risk                                         HTML     30K 
98: R33         Interest Rate Risk                                  HTML     27K 
36: R34         Liquidity Risk                                      HTML     33K 
25: R35         Subsequent Events                                   HTML     28K 
65: R36         Significant Accounting Policies (Policies)          HTML    127K 
99: R37         Significant Accounting Policies (Tables)            HTML     29K 
37: R38         Property and Equipment (Tables)                     HTML     88K 
23: R39         Accounts Payable and Accrued Liabilities (Tables)   HTML     37K 
51: R40         Convertible Notes (Tables)                          HTML     35K 
16: R41         Commitments and Contingencies (Tables)              HTML     38K 
75: R42         Share Capital (Tables)                              HTML     36K 
85: R43         Stock Options (Tables)                              HTML     55K 
52: R44         Share Based Compensation (Tables)                   HTML     34K 
17: R45         Warrants (Tables)                                   HTML     55K 
76: R46         Income Taxes (Tables)                               HTML     65K 
86: R47         Earnings Per Share (Tables)                         HTML     33K 
53: R48         Finance Income and Finance Costs (Tables)           HTML     51K 
15: R49         Segment Disclosures (Tables)                        HTML     42K 
33: R50         Concentrations (Tables)                             HTML     31K 
47: R51         Related Party Transactions (Tables)                 HTML     35K 
101: R52         Research and Development Expenses (Tables)          HTML     39K  
68: R53         Personnel Expenses (Tables)                         HTML     36K 
32: R54         Liquidity risk (Tables)                             HTML     31K 
46: R55         Significant Accounting Policies (Details)           HTML     33K 
100: R56         Significant Accounting Policies (Details            HTML     28K  
                Narrative)                                                       
67: R57         New Accounting Standards and Interpretations        HTML     35K 
                (Details Narrative)                                              
34: R58         Property and Equipment (Details)                    HTML     60K 
45: R59         Property and Equipment (Details Narrative)          HTML     28K 
90: R60         Intangible Assets (Details Narrative)               HTML     38K 
79: R61         Accounts Payable and Accrued Liabilities (Details)  HTML     34K 
14: R62         Convertible Notes (Details)                         HTML     32K 
50: R63         Convertible Notes (Details Narrative)               HTML     40K 
88: R64         Operating Leases and Commitments (Details)          HTML     31K 
77: R65         Operating Leases and Commitments (Details 1)        HTML     34K 
12: R66         Operating Leases and Commitments (Details           HTML     40K 
                Narrative)                                                       
48: R67         Share Capital (Details)                             HTML     30K 
87: R68         Share Capital (Details Narrative)                   HTML     40K 
80: R69         Stock Options (Details)                             HTML     52K 
71: R70         Stock Options (Details 1)                           HTML     43K 
102: R71         Stock Options (Details Narrative)                   HTML     30K  
41: R72         Share Based Compensation (Details)                  HTML     34K 
28: R73         Share Based Compensation (Details Narrative)        HTML     38K 
74: R74         Warrants (Details)                                  HTML     48K 
105: R75         Warrants (Details Narrative)                        HTML     36K  
44: R76         Income Taxes (Details)                              HTML     43K 
31: R77         Income Taxes (Details 1)                            HTML     33K 
69: R78         Income Taxes (Details 2)                            HTML     84K 
106: R79         Income Taxes (Details Narrative)                    HTML     28K  
72: R80         Earnings Per Share (Details)                        HTML     31K 
103: R81         Financial Instruments Fair Value Disclosures        HTML     34K  
                (Details Narrative)                                              
42: R82         Finance Income and Finance Costs (Details)          HTML     47K 
29: R83         Segment Disclosures (Details)                       HTML     43K 
73: R84         Concentrations (Details)                            HTML     32K 
104: R85         Related Party Transactions (Details)                HTML     36K  
43: R86         Related Party Transactions (Details Narrative)      HTML     36K 
30: R87         Research and Development Expenses (Details)         HTML     41K 
70: R88         Personnel Expenses (Details)                        HTML     35K 
107: R89         Capital Disclosures and Financial Risk (Details     HTML     39K  
                Narrative)                                                       
89: R90         Foreign Exchange risk (Details Narrative)           HTML     28K 
78: R91         Credit risk (Details Narrative)                     HTML     34K 
13: R92         Interest rate risk (Details Narrative)              HTML     27K 
49: R93         Liquidity risk (Details)                            HTML     35K 
66: XML         IDEA XML File -- Filing Summary                      XML    195K 
40: EXCEL       IDEA Workbook of Financial Reports                  XLSX    101K 
 6: EX-101.INS  XBRL Instance -- nymx-20191231                       XML   1.64M 
 8: EX-101.CAL  XBRL Calculations -- nymx-20191231_cal               XML    146K 
 9: EX-101.DEF  XBRL Definitions -- nymx-20191231_def                XML    448K 
10: EX-101.LAB  XBRL Labels -- nymx-20191231_lab                     XML    907K 
11: EX-101.PRE  XBRL Presentations -- nymx-20191231_pre              XML    735K 
 7: EX-101.SCH  XBRL Schema -- nymx-20191231                         XSD    307K 
54: ZIP         XBRL Zipped Folder -- 0001640334-20-000668-xbrl      Zip    133K

‘R16’ — Operating Leases and Commitments

This is an IDEA Financial Report. [ Alternative Formats ]

OPERATING LEASES AND COMMITMENTS

12 Months Ended

Dec. 31, 2019

Operating Leases And Commitments

NOTE 10 - OPERATING LEASES AND COMMITMENTS

Effective for annual reporting periods beginning on or after January 1, 2019, IFRS 16 introduced a new approach to lessee accounting that requires a lessee to recognize assets and liabilities for the rights and obligations created by leases. IFRS 16 requires a lessee to recognize assets and liabilities for all leases with a term of more than 12 months. The IASB concluded that such an approach will result in a more faithful representation of a lessee’s assets and liabilities and, together with enhanced disclosures, greater transparency of a lessee’s financial leverage and capital employed.

We adopted this standard on January 1, 2019, with an immaterial cumulative adjustment of $11,667 to accumulated deficit rather than retrospectively adjusting prior periods. This adoption approach resulted in a balance sheet presentation that is not comparable to the prior period. We used an incremental borrowing rate as a discount rate for our operating leases. The discount rate ranges from 6.89% to 7.10%. The adoption of this standard resulted in the recognition of operating lease assets of approximately $393,000 and liabilities of approximately $405,000 as of January 1,2019.

In August 2018, October 2017, the Corporation entered into or renewed its operating lease agreements for its Canadian and US (New Jersey) premises, which will expire on August 31, 2020 and October 31, 2020, respectively. The average remaining years for our lease are 1.4 year as of December 31, 2019.

The following table provides the changes in the Corporation’s operating lease right-of-use assets for the year ended December 31, 2019:

In Thousands of US Dollars
	Operation
	lease
	right-of-use
	asset
Balances as of January 1, 2019	$	393
Accumulated amortization		(253)
Other		(4)
Balances as of December 31, 2019	$	136

The following table provides the changes in the Corporation’s operating lease liability for the year ended December 31, 2019:

In Thousands of US Dollars
	Total


Balances as of January 1, 2019	$	405
Repayments of lease liability		(277)
Other		19
Balances as of December 31, 2019	$	147
Lease liability due within one year	$	144
Lease liability long term	$	3

The total future commitment payment amount for above lease is $151,805 comparing an outstanding lease liability of $147,036 as of December 31, 2019. The difference is due to borrowing rate discount.

Other operating leases commitment

Other than operating lease described in above operating lease table. the corporation renewed its operating lease for its US(California) office and the renewed lease will be treated as new lease and will be effective effective from January 1,2020 and expire on July 31,2021. This new lease will result in the recognition of operating lease assets and liabilities of approximately $144,000 as of January 1,2020.

Dates Referenced Herein

This ‘20-F’ Filing	Date	Other Filings

	10/31/20	None on these Dates
	8/31/20
Filed on:	3/30/20
For Period end:	12/31/19
	1/1/19
		List all Filings

↑Top

Filing Submission 0001640334-20-000668 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)